Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.35
+0.02 (0.27%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Gyre Therapeutics Employees
Gyre Therapeutics had 625 employees as of December 31, 2025. The number of employees increased by 46 or 7.94% compared to the previous year.
Employees
625
Change (1Y)
46
Growth (1Y)
7.94%
Revenue / Employee
$175,709
Profits / Employee
-$31,853
Market Cap
779.35M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 625 | 46 | 7.94% |
| Dec 31, 2024 | 579 | -14 | -2.36% |
| Dec 31, 2023 | 593 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Wave Life Sciences | 317 |
| Geron | 258 |
| 4D Molecular Therapeutics | 196 |
| Olema Pharmaceuticals | 150 |
| Solid Biosciences | 121 |
| Aclaris Therapeutics | 73 |
| Design Therapeutics | 55 |
| Avalo Therapeutics | 33 |
GYRE News
- 10 days ago - Gyre Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 23 days ago - Gyre Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 25 days ago - Gyre Therapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - Gyre Therapeutics Earnings release: Q2 2026 - Filings
- 7 weeks ago - Gyre Therapeutics Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Gyre Therapeutics Appoints Three New Members to its Board of Directors - GlobeNewsWire
- 2 months ago - Gyre Therapeutics Registration statement: Registration filing - Filings